CHICAGO, June 6 (UPI) -- A clinical trial shows a vaccine combined with the immune-boosting drug Interleukin-2 can improve outcomes for advanced melanoma, U.S. researchers say.
Source : Google Reader
Monday 6 June 2011
Vaccine + drug = improved melanoma outcome
Vaccine + drug = improved melanoma outcome: "
CHICAGO, June 6 (UPI) -- A clinical trial shows a vaccine combined with the immune-boosting drug Interleukin-2 can improve outcomes for advanced melanoma, U.S. researchers say.
"
CHICAGO, June 6 (UPI) -- A clinical trial shows a vaccine combined with the immune-boosting drug Interleukin-2 can improve outcomes for advanced melanoma, U.S. researchers say.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment